Crystal structure of 4-allylsulfanyl-1H-pyrazolo[3,4-d]pyrimidine

Acta Crystallographica Section E: Structure Reports Online

Volumn 70, Issue 9, 2014, Pages o1038-

  El Fal, Mohammed ^a   Ramli, Youssef ^b   Essassi, El Mokhtar ^a   Saadi, Mohamed ^a   El Ammari, Lahcen ^a  

^a FACULTÉ DES SCIENCES   (Morocco)

^b Madinat Al Irnane   (Morocco)

Author keywords

crystal structure; disorder; pyrazolopyrimidine; thiopyrazolopyrimidine

Indexed keywords

EID: 84907013856     PISSN: None     EISSN: 16005368     Source Type: Journal    
DOI: 10.1107/S1600536814018042     Document Type: Article

References (10)

1. Alsubari, A., Ramli, Y., Essassi, E. M. &Zouihri, H. (2011). Acta Cryst. E67, o1926.
2. Ballell, L., Field, R. A., Chung, G. A. C. &Young, R. J. (2007). Bioorg. Med. Chem. Lett. 17, 1736-1740.
3. Bruker (2009). APEX2, SAINT-Plus and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.
4. El Fal, M., Ramli, Y., Essassi, E. M., Saadi, M. &El Ammari, L. (2013). Acta Cryst. E69, o1650.
5. Farrugia, L. J. (2012). J. Appl. Cryst. 45, 849-854.
6. Rashad, A. E., Abeer, E. M. &Mamdouh, M. A. (2011). Eur. J. Med. Chem. 46, 1019-1026.
7. Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
8. Spek, A. L. (2009). Acta Cryst. D65, 148-155.
9. Westrip, S. P. (2010). J. Appl. Cryst. 43, 920-925.
10. Yuan, L., Chang, W. S., Cai, H., Ying, L., Dong, L. &Shu, F. Y. (2013). Eur. J. Med. Chem. 67, 152-157.